Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development.
about
Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Up-regulation of hexokinase II ...... t for therapeutic development.
@en
Up-regulation of hexokinase II ...... t for therapeutic development.
@nl
type
label
Up-regulation of hexokinase II ...... t for therapeutic development.
@en
Up-regulation of hexokinase II ...... t for therapeutic development.
@nl
prefLabel
Up-regulation of hexokinase II ...... t for therapeutic development.
@en
Up-regulation of hexokinase II ...... t for therapeutic development.
@nl
P2093
P2860
P356
P1433
P1476
Up-regulation of hexokinase II ...... et for therapeutic development
@en
P2093
Anil Singh
Cory Mavis
Francisco J Hernandez-Ilizaliturri
Georg Lenz
Matthew Barth
Myron S Czuczman
Peter Lenz
Vivek Yanamadala
P2860
P304
P356
10.18632/ONCOTARGET.23425
P407
P50
P577
2017-12-19T00:00:00Z